TARSyn: Tunable Antibiotic Resistance Devices Enabling Bacterial Synthetic Evolution and Protein Production

被引:26
作者
Rennig, Maja [1 ]
Martinez, Virinia [1 ]
Mirzadeh, Kiavash [2 ,3 ]
Dunas, Finn [4 ]
Rojsater, Belinda [4 ]
Daley, Daniel O. [2 ,3 ]
Norholm, Morten H. H. [1 ,3 ]
机构
[1] Tech Univ Denmark, Ctr Biosustainabil, Novo Nordisk Fdn, DK-2800 Lyngby, Denmark
[2] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden
[3] CloneOpt AB, S-19468 Upplands Vasby, Sweden
[4] Affibody AB, S-17169 Solna, Sweden
基金
瑞典研究理事会;
关键词
protein production; antibiotic resistance; translational coupling; selection system; synthetic evolution; translation initiation region; ESCHERICHIA-COLI; BIOCHEMICAL FUNDAMENTALS; MEMBRANE-PROTEINS; GENE-EXPRESSION; RNA STRUCTURE; TRANSLATION; CODON; INITIATION; SEQUENCE; FUSION;
D O I
10.1021/acssynbio.7b00200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Evolution can be harnessed to optimize synthetic biology designs. A prominent example is recombinant protein production-a dominating theme in biotechnology for more than three decades. Typically, a protein coding sequence (cds) is recombined with genetic elements, such as promoters, ribosome binding sites and terminators, which control expression in a cell factory. A major bottleneck during production is translational initiation. Previously we identified more effective translation initiation regions (TIRs) by creating sequence libraries and then selecting for a TIR that drives high-level expression-an example of synthetic evolution. However, manual screening limits the ability to assay expression levels of all putative sequences in the libraries. Here we have solved this bottleneck by designing a collection of translational coupling devices based on a RNA secondary structure. Exchange of different sequence elements in this device allows for different coupling efficiencies, therefore giving the devices a tunable nature. Sandwiching these devices between the cds and an antibiotic selection marker that functions over a broad dynamic range of antibiotic concentrations adds to the tunability and allows expression levels in large clone libraries to be probed using a simple cell survival assay on the respective antibiotic. The power of the approach is demonstrated by substantially increasing production of two commercially interesting proteins, a Nanobody and an Affibody. The method is a simple and inexpensive alternative to advanced screening techniques that can be carried out in any laboratory.
引用
收藏
页码:432 / 442
页数:21
相关论文
共 52 条
[1]   Protein expression using ubiquitin fusion and cleavage [J].
Baker, RT .
CURRENT OPINION IN BIOTECHNOLOGY, 1996, 7 (05) :541-546
[2]   In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin- binding therapeutic affibody construct [J].
Bass, Tarek Z. ;
Rosestedt, Maria ;
Mitran, Bogdan ;
Frejd, Fredrik Y. ;
Lofblom, John ;
Tolmachev, Vladimir ;
Stahl, Stefan ;
Orlova, Anna .
SCIENTIFIC REPORTS, 2017, 7
[3]   Efficient translation initiation dictates codon usage at gene start [J].
Bentele, Kajetan ;
Saffert, Paul ;
Rauscher, Robert ;
Ignatova, Zoya ;
Bluethgen, Nils .
MOLECULAR SYSTEMS BIOLOGY, 2013, 9
[4]  
Bonde MT, 2016, NAT METHODS, V13, P233, DOI [10.1038/nmeth.3727, 10.1038/NMETH.3727]
[5]   Translation rate is controlled by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at upstream standby sites [J].
Borujeni, Amin Espah ;
Channarasappa, Anirudh S. ;
Salis, Howard M. .
NUCLEIC ACIDS RESEARCH, 2014, 42 (04) :2646-2659
[6]   Accurate DNA Assembly and Genome Engineering with Optimized Uracil Excision Cloning [J].
Cavaleiro, Ana Mafalda ;
Kim, Se Hyeuk ;
Seppala, Susanna ;
Nielsen, Morten T. ;
Norholm, Morten H. H. .
ACS SYNTHETIC BIOLOGY, 2015, 4 (09) :1042-1046
[7]   DETERMINATION OF THE OPTIMAL ALIGNED SPACING BETWEEN THE SHINE-DALGARNO SEQUENCE AND THE TRANSLATION INITIATION CODON OF ESCHERICHIA-COLI MESSENGER-RNAS [J].
CHEN, HY ;
BJERKNES, M ;
KUMAR, R ;
JAY, E .
NUCLEIC ACIDS RESEARCH, 1994, 22 (23) :4953-4957
[8]   Translational standby sites: How ribosomes may deal with the rapid folding kinetics of mRNA [J].
de Smit, MH ;
van Duin, J .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 331 (04) :737-743
[9]   Optimizing Protein Stability In Vivo [J].
Foit, Linda ;
Morgan, Gareth J. ;
Kern, Maximilian J. ;
Steimer, Lenz R. ;
von Hacht, Annekathrin A. ;
Titchmarsh, James ;
Warriner, Stuart L. ;
Radford, Sheena E. ;
Bardwell, James C. A. .
MOLECULAR CELL, 2009, 36 (05) :861-871
[10]   Affibody molecules as engineered protein drugs [J].
Frejd, Fredrik Y. ;
Kim, Kyu-Tae .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2017, 49 :e306-e306